CpG Oligodeoxynucleotides: A Novel Therapeutic Approach For Atopic Disorders

Publisher： Bentham Science Publishers

E-ISSN： 1875-5933|2|3|199-205

ISSN： 1568-010X

Source： Current Drug Targets. Inflammation & Allergy, Vol.2, Iss.3, 2003-09, pp. : 199-205

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Review of the Role of CpG Oligodeoxynucleotides as Toll-Like Receptor 9 Agonists in Prophylactic and Therapeutic Vaccine Development in Infectious Diseases

By Gupta Kaveri  

Drugs in R&D, Vol. 9, Iss. 3, 2008-01 ,pp. : 137-145

Adis International

Access to resources Recommend Favorite

Immunotherapeutic potential of CpG oligodeoxynucleotides in veterinary species

By Manuja Anju   Manuja Balvinder K.   Kaushik Jyoti   Singha Harisankar   Singh Raj Kumar  

Immunopharmacology and Immunotoxicology, Vol. 35, Iss. 5, 2013-10 ,pp. : 535-544

Informa Healthcare

Access to resources Recommend Favorite

Synthetic Oligodeoxynucleotides Containing Deoxycytidyl-Deoxyguanosine Dinucleotides (CpG ODNs) and Modified Analogs as Novel Anticancer Therapeutics

By  

Current Pharmaceutical Design, Vol. 11, Iss. 22, 2005-08 ,pp. : 2889-2907

Bentham Science Publishers

Access to resources Recommend Favorite

CpG oligodeoxynucleotides: postexposure prophylaxis for prion diseases?

By  

Inpharma, Vol. 1, Iss. 1348, 2002-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Immune effects and therapeutic applications of CpG motifs in bacterial DNA

By Krieg A.M.   Kline J.N.  

Immunopharmacology, Vol. 48, Iss. 3, 2000-07 ,pp. : 303-305

Elsevier

Access to resources Recommend Favorite